GLP-1 weight loss injections are primarily used for patients managing type 2 diabetes, although patients still see weight loss results
4-6 Only three GLP-1 medications are currently FDA approved for weight loss: liraglutide (Saxenda), semaglutide (Wegovy) and tirzepatide (Zepbound)
It also affects telomere integrity and sleep quality
the individual-compound trials that do exist are small, decades-old, and often in patient (not healthy-adult) populations
Doctor raises purity, side effect concerns The medications approved by Health Canada are often prescribed by a doctor, such as glucagon-like peptide-1 receptor agonists, or GLP-1s, a class that includes Ozempic, Wegovy and Mounjaro injections used to treat obesity and diabetes
Just when you thought you knew what to expect with GLP-1s, new research emerges that gives you pause